PM

Palem Manikanta Reddy

Active Director Designated Partner DIN 08626438
DIN 08626438 First appointment Dec 2019 Primary industry Business Outsourcing
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Palem Manikanta Reddy

Data last updated:

Palem Manikanta Reddy is a Designated Partner at Samson Clinical Courses Llp (since 2019). The company operates in Business Outsourcing.

DIN 08626438
Primary Designation Designated Partner
Industry Business Outsourcing
First Appointment 02 Dec 2019
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner02 Dec 20192019Active

Board colleagues of Palem Manikanta Reddy

NameDINCompanyDesignation
Abdul Khader Batcha Irfana Pharveen08626437Samson Clinical Courses LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Samson Clinical Courses Llp
Premium access

Shareholding and investment profile for Palem Manikanta Reddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Palem Manikanta Reddy

Palem Manikanta Reddy currently holds 1 directorship: Samson Clinical Courses Llp (Designated Partner, since 02 Dec 2019).

Palem Manikanta Reddy was first appointed on 02 Dec 2019 as Designated Partner at Samson Clinical Courses Llp.

The current boards of Palem Manikanta Reddy's companies include Abdul Khader Batcha Irfana Pharveen (Samson Clinical Courses Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available